StonvexLoading…
StonvexStonvexStonvexCore line items from AXON's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $807.35M | $2.78B | $1.98B | $1.27B |
Operating Income | $29.24M | $-62.08M | $-11.96M | $-9.83M |
Net Income | $169.31M | $124.66M | $121.91M | $36.12M |
EPS (Diluted) | $2.05 | $1.51 | $1.48 | $1.52 |
Total Assets | $7.07B | $7.00B | $6.66B | $6.22B |
Total Liabilities | $3.53B | $3.76B | $3.63B | $3.48B |
Cash & Equivalents | $458.92M | $1.20B | $1.42B | $615.50M |
Free Cash Flow OCF − CapEx | $-54.64M | $75.08M | $-80.35M | $-113.72M |
Shares Outstanding | 80.57M | 80.21M | 78.89M | 78.50M |